Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Single Module, Pick-and-Place HP 140 Series

November 29, 2012 10:52 am | Product Releases | Comments

Industry leading specialist for rotary tables and automation WEISS North America, Inc. (Willoughby, OH), continues to evolve its HP 140 Pick-and-Place series with a myriad of superior performance capabilities vs. traditional pneumatic systems.

Medical-Grade High-Efficiency 150 Watt Power Supply

November 29, 2012 10:44 am | SL Power Electronics, Corp. | Product Releases | Comments

SL Power Electronics, a division of SL Industries and an industry leader in the design and manufacture of medical power supplies, today announces its latest medically approved high-efficiency MINT1150 AC/DC power supply.

Ultra High-Density Single-Output 160W AC/DC Power Supplies

November 29, 2012 10:22 am | Product Releases | Comments

LHV Power Corporation has introduced a state-of-the-art family of ultra high-density AC/DC single-output power supplies that provide up to 160 watts of continuous power at typical efficiencies of 90 percent.

Advertisement

CMM Products Brochure

November 29, 2012 10:14 am | Product Releases | Comments

A new 10-page, 4-color, brochure highlighting the COORD3 line of CMM products is now available from COORD3 Metrology. The brochure can be found on the COORD3.com web site for downloading...

OPKO Health Announces Research Grants from Mexican Technology and Science Council

November 29, 2012 9:23 am | by The Associated Press | News | Comments

MIAMI--(BUSINESS WIRE)--Nov 29, 2012--OPKO Health, Inc. (NYSE: OPK) today announced the award of research grants from the Mexican National Technology and Science Council (Consejo Nacional de Ciencia y Tecnología, CONACYT). The grants will be used by Exakta-OPKO, OPKO's wholly-owned Mexican...

CardiAQ™ Valve Technologies, Inc. Completes $37.3 Million Series B Round of Financing Led by OrbiMed Advisors LLC

November 29, 2012 9:04 am | by The Associated Press | News | Comments

IRVINE, Calif.--(BUSINESS WIRE)--Nov 29, 2012--CardiAQ™ Valve Technologies, Inc., a privately held medical device company developing technologies for percutaneous mitral heart valve replacement, announced today that it received $37.3 million in funding in its second round of equity financing....

Fidelis Diagnostics Expands Services in Southern California by Adding EMG Testing to Its Portfolio

November 29, 2012 9:01 am | by The Associated Press | News | Comments

LOS ANGELES--(BUSINESS WIRE)--Nov 29, 2012--Fidelis Diagnostics, Inc., a rapidly growing healthcare company providing innovative diagnostic services nationally, announced it is expanding its portfolio of diagnostic services in Southern California and adding physicians to its medical team and a new...

Video: Nanosphere's Breakthrough Technology Allowing Earlier Detection and More Targeted Treatment

November 29, 2012 8:36 am | by The Associated Press | News | Comments

"Diagnostics is proving to be a more and more important element of overall patient care,"says William Moffitt, President and Chief Executive Officer of Nanosphere, Inc. (Nasdaq: NSPH) - a developer and manufacturer of an advanced molecular diagnostic platform which enables simple,...

Advertisement

Illumina Names Dr. Robert S. Epstein to its Board of Directors

November 29, 2012 6:30 am | by The Associated Press | News | Comments

SAN DIEGO--(BUSINESS WIRE)--Nov 29, 2012--Illumina, Inc. (NASDAQ: ILMN) today announced that Dr. Robert S. Epstein, M.D., has joined the company’s Board of Directors. Dr. Epstein is an epidemiologist who worked in public health and academia before joining the private sector. Previously, from 2010...

Letter to Industry Announcing the Launch of the CDRH Export Certification and Tracking System (CECATS)

November 29, 2012 12:00 am | by U.S. Food & Drug Administration | News | Comments

Today the FDA?s Center for Devices and Radiological Health (CDRH) launched the first phase of a new, Internet-based system for submitting and processing export document requests. The CDRH Export Certification and Tracking System (CECATS) will allow...

Abbott Labs' Worcester facility to become part of spinoff

November 29, 2012 12:00 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Abbott Laboratories’ (NYSE: ABT) board of directors has voted in favor of a planned spinoff of its pharmaceuticals business, the company said Thursday. As of Jan. 1, 2013, the new drug division, called AbbVie, will begin trading on its own with the ticker symbol (Nasdaq: ABBV).

Spain’s Era7 Bioinformatics opens Cambridge office

November 29, 2012 12:00 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Era7 Bioinformatics, a Spanish bioinformatics company specializing in bacterial genomics, has opened its first U.S. office, located in the Cambridge Innovation Center (CIC), and expects to hire three employees by the end of 2013.

CDRH Export Certification Application and Tracking System (CECATS) Frequently Asked Questions

November 29, 2012 12:00 am | by U.S. Food & Drug Administration | News | Comments

What is CECATS? CECATS is CDRH?s web-based application for accepting requests, reviewing, processing, managing, and administering export certificates, simple notifications, and export permit letters. In the first phase, which begins in November 2012...

Obagi Medical Products to Present at The Canaccord Genuity’s Medical Technology and Diagnostics Forum Conference

November 28, 2012 4:33 pm | by The Associated Press | News | Comments

LONG BEACH, Calif.--(BUSINESS WIRE)--Nov 28, 2012--Obagi Medical Products, Inc. (NASDAQ: OMPI), a leader in topical aesthetic and therapeutic skin health systems, today announced that President and Chief Executive Officer Albert Hummel will present a corporate overview at The Canaccord Genuity’s...

Velomedix Receives IDE Approval for Randomized Pilot Trial to Evaluate Rapid Therapeutic Hypothermia in the Management of Acute Myocardial Infarction Patients

November 28, 2012 3:54 pm | by The Associated Press | News | Comments

MENLO PARK, Calif.--(BUSINESS WIRE)--Nov 28, 2012--Velomedix, Inc., a venture-backed medical device company advancing the field of therapeutic hypothermia, announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to expand the...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading